Portfolio Company News Archives - Page 2 of 37 - USVP/

Neuros Medical Secures $56M Series D to Commercialize the Altius® System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain

Cato Networks Raises $359 Million at a Valuation of More Than $4.8 Billion

Zero Networks Raises $55M Series C to Usher in the “Era of the Defender”

Heartflow Closes $98 Million Convertible Notes Financing

MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing

Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief

Delfina Raises $17M to Revolutionize Maternal Health with AI-Powered Care

Quantifind Raises $22 Million to Deliver Proven AI Compliance Solutions Globally and Launches its Payments Risk Intelligence Solution to Meet Escalating Demands

Stream.Security Secures $30 Million in Series B Funding